statistiche ricercatore

Continente	#
EU - Europa	11.392
NA - Nord America	880
AS - Asia	601
SA - Sud America	81
Continente sconosciuto - Info sul continente non disponibili	50
AF - Africa	16
OC - Oceania	3
Totale	13.023

Nazione	#
IT - Italia	11.137
US - Stati Uniti d'America	851
SG - Singapore	223
CN - Cina	159
SE - Svezia	78
VN - Vietnam	67
BR - Brasile	57
FR - Francia	39
DE - Germania	38
IN - India	31
HK - Hong Kong	28
GB - Regno Unito	22
CA - Canada	21
NL - Olanda	20
FI - Finlandia	17
BD - Bangladesh	10
AT - Austria	9
IQ - Iraq	9
KR - Corea	9
PL - Polonia	8
AE - Emirati Arabi Uniti	7
AR - Argentina	7
IR - Iran	7
TR - Turchia	7
VE - Venezuela	6
ZA - Sudafrica	6
ID - Indonesia	5
JP - Giappone	5
PH - Filippine	5
RU - Federazione Russa	5
SA - Arabia Saudita	5
ES - Italia	4
GR - Grecia	4
IE - Irlanda	4
IL - Israele	4
PK - Pakistan	4
TH - Thailandia	4
UZ - Uzbekistan	4
AU - Australia	3
CL - Cile	3
EC - Ecuador	3
MA - Marocco	3
BB - Barbados	2
BH - Bahrain	2
CO - Colombia	2
MX - Messico	2
NG - Nigeria	2
TN - Tunisia	2
AL - Albania	1
AZ - Azerbaigian	1
BO - Bolivia	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
HR - Croazia	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
LT - Lituania	1
LU - Lussemburgo	1
MN - Mongolia	1
MO - Macao, regione amministrativa speciale della Cina	1
MY - Malesia	1
NO - Norvegia	1
OM - Oman	1
PE - Perù	1
PT - Portogallo	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
Totale	12.973

Nome	#
Molecular-biology-driven treatment for metastatic colorectal cancer	2.778
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment	1.371
Molecular-driven treatment for biliary tract cancer: the promising turning point	1.226
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors	1.095
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?	943
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression	885
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment	877
Uncovering key targets of success for immunotherapy in pancreatic cancer	730
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus	682
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials	653
BRCA-mutant pancreatic ductal adenocarcinoma	624
Immune Checkpoint Inhibitors in the Treatment of HCC	598
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score	349
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients	212
Totale	13.023

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.094	0	48	3	25	40	84	56	120	69	95	188	366
2022/2023	2.498	275	375	260	167	184	233	115	157	164	292	182	94
2023/2024	1.946	79	56	80	107	166	354	365	160	97	97	186	199
2024/2025	4.934	1.486	1.641	403	463	209	319	214	26	37	51	31	54
2025/2026	1.479	130	82	105	116	96	105	342	139	96	124	56	88
2026/2027	60	21	39	0	0	0	0	0	0	0	0	0	0
Totale													13.023

UNICA IRIS Institutional Research Information System